• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115

(1S,5S,6R)-5-(Acetyloxy)-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Methyl Ester

The compound with CAS No. 494195-98-1, known as (1S,5S,6R)-5-(Acetyloxy)-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Methyl Ester, is a highly specialized organic molecule with a complex bicyclic structure. This compound has garnered significant attention in the fields of organic chemistry and pharmacology due to its unique stereochemistry and potential bioactivity.

Recent studies have highlighted the importance of bicyclic compounds like this one in drug discovery. The bicyclo[4.1.0]heptane framework is particularly interesting because it offers a rigid structure that can be tailored to interact with specific biological targets. The presence of an acetyloxy group and a methyl ester further enhances the compound's functional diversity, making it a promising candidate for various applications.

In terms of synthesis, researchers have developed efficient methods to construct this compound using a combination of ring-closing metathesis and stereoselective oxidation techniques. These methods not only ensure high yields but also maintain the stereochemical integrity required for biological testing.

From a pharmacological perspective, this compound has shown potential as a lead molecule in the development of new drugs targeting specific enzymes or receptors. Its ability to modulate enzyme activity has been demonstrated in vitro, suggesting that it could serve as a starting point for further optimization.

The stereochemistry of this compound is critical to its function. The specific configuration at the (1S,5S,6R) positions plays a significant role in determining its interactions with biological systems. This highlights the importance of stereochemical control in organic synthesis and drug design.

Looking ahead, ongoing research is focused on understanding the compound's pharmacokinetics and toxicity profile to assess its suitability for in vivo studies. Additionally, efforts are being made to explore its potential applications in areas such as anti-inflammatory therapy and cancer treatment.

In conclusion, (1S,5S,6R)-5-(Acetyloxy)-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Methyl Ester represents a fascinating example of how complex organic molecules can be designed and synthesized to address pressing challenges in modern medicine.

• 171596-14-8((1R,5S,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid)
• 111035-65-5(Annonacin)
• 167172-78-3(Annomuricin A)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)